Healthcare stocks are moderately higher today with the NYSE
Healthcare Sector Index adding 0.4% and shares of healthcare
companies in the S&P 500 rising 0.3% as a group.
In company news, Amarin (
) is down 18% at $5.23 a share, earlier falling within 3 cents of
its 52-week low of $5.15 after the U.S. Food and Drug
Administration today released briefing documents for an Oct. 16
advisory panel review of the company's supplemental new drug
application for its Vascepa anti-cholesterol drug.
According to the documents, there were no new safety signals
identified with the drug, adding the safety profile during Phase
III testing was consistent with current labeling and post-market
But the documents also raised issues with the company's use of
mineral oil as a placebo during the clinical trial, which the FDA
believes may have muddled interpretation of the results.
In other sector news,
(+) ANGO, Non-GAAP adjusted earnings of $0.12 per share beat by
$0.07 while its $83.6 mln in net sales top analyst estimates by
$1.1 mln. Raises EPS, sales forecasts for Q2 and FY14 above Street
(-) ASTM, Announces 20-for-1 reverse stock split in a move
intended to lift stock price above $1 Nasdaq minimum
Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.